A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.
Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart M; BIG-NABCG collaboration.
Fumagalli D, et al. Among authors: esserman l.
Lancet Oncol. 2012 Jun;13(6):e240-8. doi: 10.1016/S1470-2045(11)70378-3.
Lancet Oncol. 2012.
PMID: 22652232